Availability: Science, politics and the pharmaceutical industry

Saved in:

Bibliographic Details
Main Author:	Abraham, John (Author)
Format:	Book
Language:	English
Published:	New York St. Martin's Press 1995
Edition:	1. ed.
Subjects:	Politik Clinical Trials > Great Britain > Case Reports Clinical Trials > United States > Case Reports Drug Approval > Great Britain Drug Approval > United States Drug Industry > Great Britain Drug Industry > United States Drug and Narcotic Control > Great Britain Drug and Narcotic Control > United States Drugs > Testing > Government policy > Great Britain Drugs > Testing > Government policy > United States Drugs > Toxicology > Case studies Arzneimittel Arzneimittelsicherheit Gesundheitspolitik Zulassung Großbritannien USA Fallstudiensammlung
Links:	http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007296822&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
Physical Description:	XI, 308 S.
ISBN:	0312128738

Staff View

MARC


LEADER	00000nam a2200000 c 4500
001	BV010908627
003	DE-604
005	00000000000000.0
007	t\|
008	960822s1995 xx \|\|\|\| 00\|\|\| eng d
020			\|a 0312128738 \|9 0-312-12873-8
035			\|a (OCoLC)32468449
035			\|a (DE-599)BVBBV010908627
040			\|a DE-604 \|b ger \|e rakddb
041	0		\|a eng
049			\|a DE-12
050		0	\|a RM301.27
082	0		\|a 615/.19 \|2 20
100	1		\|a Abraham, John \|e Verfasser \|4 aut
245	1	0	\|a Science, politics and the pharmaceutical industry \|b controversy and bias in drug regulation \|c John Abraham
250			\|a 1. ed.
264		1	\|a New York \|b St. Martin's Press \|c 1995
300			\|a XI, 308 S.
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
650		4	\|a Politik
650		4	\|a Clinical Trials \|z Great Britain \|v Case Reports
650		4	\|a Clinical Trials \|z United States \|v Case Reports
650		4	\|a Drug Approval \|z Great Britain
650		4	\|a Drug Approval \|z United States
650		4	\|a Drug Industry \|z Great Britain
650		4	\|a Drug Industry \|z United States
650		4	\|a Drug and Narcotic Control \|z Great Britain
650		4	\|a Drug and Narcotic Control \|z United States
650		4	\|a Drugs \|x Testing \|x Government policy \|z Great Britain
650		4	\|a Drugs \|x Testing \|x Government policy \|z United States
650		4	\|a Drugs \|x Toxicology \|v Case studies
650	0	7	\|a Arzneimittel \|0 (DE-588)4003115-9 \|2 gnd \|9 rswk-swf
650	0	7	\|a Arzneimittelsicherheit \|0 (DE-588)4143182-0 \|2 gnd \|9 rswk-swf
650	0	7	\|a Gesundheitspolitik \|0 (DE-588)4113743-7 \|2 gnd \|9 rswk-swf
650	0	7	\|a Zulassung \|0 (DE-588)4127410-6 \|2 gnd \|9 rswk-swf
651		4	\|a Großbritannien
651		4	\|a USA
651		7	\|a USA \|0 (DE-588)4078704-7 \|2 gnd \|9 rswk-swf
651		7	\|a Großbritannien \|0 (DE-588)4022153-2 \|2 gnd \|9 rswk-swf
655		7	\|0 (DE-588)4522595-3 \|a Fallstudiensammlung \|2 gnd-content
689	0	0	\|a USA \|0 (DE-588)4078704-7 \|D g
689	0	1	\|a Arzneimittelsicherheit \|0 (DE-588)4143182-0 \|D s
689	0	2	\|a Gesundheitspolitik \|0 (DE-588)4113743-7 \|D s
689	0		\|5 DE-604
689	1	0	\|a Großbritannien \|0 (DE-588)4022153-2 \|D g
689	1	1	\|a Arzneimittelsicherheit \|0 (DE-588)4143182-0 \|D s
689	1	2	\|a Gesundheitspolitik \|0 (DE-588)4113743-7 \|D s
689	1		\|5 DE-604
689	2	0	\|a USA \|0 (DE-588)4078704-7 \|D g
689	2	1	\|a Arzneimittel \|0 (DE-588)4003115-9 \|D s
689	2	2	\|a Zulassung \|0 (DE-588)4127410-6 \|D s
689	2		\|5 DE-604
689	3	0	\|a Großbritannien \|0 (DE-588)4022153-2 \|D g
689	3	1	\|a Arzneimittel \|0 (DE-588)4003115-9 \|D s
689	3	2	\|a Zulassung \|0 (DE-588)4127410-6 \|D s
689	3		\|5 DE-604
856	4	2	\|m HBZ Datenaustausch \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007296822&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
943	1		\|a oai:aleph.bib-bvb.de:BVB01-007296822

Record in the Search Index

_version_	1819332267062853632
adam_text	Contents Abbreviations v Preface vii 1 Bias in science and regulation 2 Partial progress? The development of American and British drug regulation 36 3 Naprosyn — reconstructing data 87 4 Opren/Orajkx the making of a drug disaster 98 5 Feldme the closure of technical dispute 179 6 Zjrniax the persistence of data 206 7 Suprol anything goes? 231 8 Conclusions and policy implications 241 Notes 259 Index 303 iii
any_adam_object	1
author	Abraham, John
author_facet	Abraham, John
author_role	aut
author_sort	Abraham, John
author_variant	j a ja
building	Verbundindex
bvnumber	BV010908627
callnumber-first	R - Medicine
callnumber-label	RM301
callnumber-raw	RM301.27
callnumber-search	RM301.27
callnumber-sort	RM 3301.27
callnumber-subject	RM - Therapeutics and Pharmacology
ctrlnum	(OCoLC)32468449 (DE-599)BVBBV010908627
dewey-full	615/.19
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	615 - Pharmacology and therapeutics
dewey-raw	615/.19
dewey-search	615/.19
dewey-sort	3615 219
dewey-tens	610 - Medicine and health
discipline	Medizin
edition	1. ed.
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02908nam a2200745 c 4500</leader><controlfield tag="001">BV010908627</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t\|</controlfield><controlfield tag="008">960822s1995 xx \|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0312128738</subfield><subfield code="9">0-312-12873-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)32468449</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010908627</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.27</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">20</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Abraham, John</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Science, politics and the pharmaceutical industry</subfield><subfield code="b">controversy and bias in drug regulation</subfield><subfield code="c">John Abraham</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">St. Martin's Press</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 308 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials</subfield><subfield code="z">Great Britain</subfield><subfield code="v">Case Reports</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials</subfield><subfield code="z">United States</subfield><subfield code="v">Case Reports</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval</subfield><subfield code="z">Great Britain</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">Great Britain</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug and Narcotic Control</subfield><subfield code="z">Great Britain</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug and Narcotic Control</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield><subfield code="x">Government policy</subfield><subfield code="z">Great Britain</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield><subfield code="x">Government policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Toxicology</subfield><subfield code="v">Case studies</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">Großbritannien</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4522595-3</subfield><subfield code="a">Fallstudiensammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Großbritannien</subfield><subfield code="0">(DE-588)4022153-2</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007296822&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007296822</subfield></datafield></record></collection>
genre	(DE-588)4522595-3 Fallstudiensammlung gnd-content
genre_facet	Fallstudiensammlung
geographic	Großbritannien USA USA (DE-588)4078704-7 gnd Großbritannien (DE-588)4022153-2 gnd
geographic_facet	Großbritannien USA
id	DE-604.BV010908627
illustrated	Not Illustrated
indexdate	2024-12-20T10:03:00Z
institution	BVB
isbn	0312128738
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-007296822
oclc_num	32468449
open_access_boolean
owner	DE-12
owner_facet	DE-12
physical	XI, 308 S.
publishDate	1995
publishDateSearch	1995
publishDateSort	1995
publisher	St. Martin's Press
record_format	marc
spellingShingle	Abraham, John Science, politics and the pharmaceutical industry controversy and bias in drug regulation Politik Clinical Trials Great Britain Case Reports Clinical Trials United States Case Reports Drug Approval Great Britain Drug Approval United States Drug Industry Great Britain Drug Industry United States Drug and Narcotic Control Great Britain Drug and Narcotic Control United States Drugs Testing Government policy Great Britain Drugs Testing Government policy United States Drugs Toxicology Case studies Arzneimittel (DE-588)4003115-9 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Zulassung (DE-588)4127410-6 gnd
subject_GND	(DE-588)4003115-9 (DE-588)4143182-0 (DE-588)4113743-7 (DE-588)4127410-6 (DE-588)4078704-7 (DE-588)4022153-2 (DE-588)4522595-3
title	Science, politics and the pharmaceutical industry controversy and bias in drug regulation
title_auth	Science, politics and the pharmaceutical industry controversy and bias in drug regulation
title_exact_search	Science, politics and the pharmaceutical industry controversy and bias in drug regulation
title_full	Science, politics and the pharmaceutical industry controversy and bias in drug regulation John Abraham
title_fullStr	Science, politics and the pharmaceutical industry controversy and bias in drug regulation John Abraham
title_full_unstemmed	Science, politics and the pharmaceutical industry controversy and bias in drug regulation John Abraham
title_short	Science, politics and the pharmaceutical industry
title_sort	science politics and the pharmaceutical industry controversy and bias in drug regulation
title_sub	controversy and bias in drug regulation
topic	Politik Clinical Trials Great Britain Case Reports Clinical Trials United States Case Reports Drug Approval Great Britain Drug Approval United States Drug Industry Great Britain Drug Industry United States Drug and Narcotic Control Great Britain Drug and Narcotic Control United States Drugs Testing Government policy Great Britain Drugs Testing Government policy United States Drugs Toxicology Case studies Arzneimittel (DE-588)4003115-9 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Zulassung (DE-588)4127410-6 gnd
topic_facet	Politik Clinical Trials Great Britain Case Reports Clinical Trials United States Case Reports Drug Approval Great Britain Drug Approval United States Drug Industry Great Britain Drug Industry United States Drug and Narcotic Control Great Britain Drug and Narcotic Control United States Drugs Testing Government policy Great Britain Drugs Testing Government policy United States Drugs Toxicology Case studies Arzneimittel Arzneimittelsicherheit Gesundheitspolitik Zulassung Großbritannien USA Fallstudiensammlung
url	http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007296822&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv	AT abrahamjohn sciencepoliticsandthepharmaceuticalindustrycontroversyandbiasindrugregulation

Availability

‌

Order via interlibrary loan
Table of Contents